Canada - English - Health Canada

boehringer ingelheim animal health canada inc. - afoxolaner - tablet (chewable) - 28.3mg - afoxolaner 28.3mg - dogs

Canada - English - Health Canada

boehringer ingelheim animal health canada inc. - afoxolaner - tablet (chewable) - 68mg - afoxolaner 68mg - dogs

Canada - English - Health Canada

boehringer ingelheim animal health canada inc. - afoxolaner - tablet (chewable) - 136mg - afoxolaner 136mg - dogs

United States - English - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - firocoxib (unii: y6v2w4s4wt) (firocoxib - unii:y6v2w4s4wt) - equioxx tablets are administered once daily for up to 14 days for the control of pain and inflammation associated with osteoarthritis in horses. horses with a hypersensitivity to firocoxib should not receive equioxx® tablets.

United States - English - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - cephapirin benzathine (unii: 90g868409o) (cephapirin - unii:89b59h32vn) - cephapirin 300 mg in 10 ml - for the treatment of mastitis in dairy cows during the dry period. tomorrow has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows, when caused by streptococcus agalactiae and staphylococcus aureus including penicillin-resistant strains. treatment of the dry cow with tomorrow is indicated in any cow known to harbor any of these organisms in the udder at drying off. indicaciones para el tratamiento de mastitis bovina durante el período seco. extensos estudios clínicos han demostrado que tomorrow es eficaz en el tratamiento de la mastitis en vacas secas, cuando ésta es causada por el streptococcus agalactiae y el staphylococcus aureus, incluyendo cepas resistentes a la penicilina. el tratamiento de la vaca seca con tomorrow es recomendado para cualquier vaca que se sepa alberga a cualquiera de estos organismos en la ubre al momento del período de secado. not for human use. este producto no es para administrarse en humanos.

United States - English - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - cephapirin sodium (unii: 431lff7i7j) (cephapirin - unii:89b59h32vn) - cephapirin 200 mg in 10 ml - for lactating cows only / for the treatment of bovine mastitis today (cephapirin sodium) for intramammary infusion should be used at the first signs of inflammation or at the first indication of any alteration in the milk. treatment is indicated immediately upon determining, by c.m.t. or other tests, that the leukocyte count is elevated, or that a susceptible pathogen has been cultured from the milk. today for intramammary infusion has been shown to be efficacious in the treatment of mastitis in lactating cows caused by susceptible strains of streptococcus agalactiae and staphylococcus aureus including strains resistant to penicillin. indicaciones Únicamente para vacas lactantes / para el tratamiento de mastitis bovina today (cefapirina sódica) para infusión intramamaria deberá administrarse desde los primeros signos de inflamación o al primer indicio de cualquier alteración de la leche. el tratamiento resulta indicado inmediatamente después de determinar mediante la prueba de california para mastitis (c.m.

Canada - English - Health Canada

boehringer ingelheim animal health canada inc. - afoxolaner; milbemycin oxime - tablet (chewable) - 9.4mg; 1.9mg - afoxolaner 9.4mg; milbemycin oxime 1.9mg - dogs

Canada - English - Health Canada

boehringer ingelheim animal health canada inc. - afoxolaner; milbemycin oxime - tablet (chewable) - 18.8mg; 3.8mg - afoxolaner 18.8mg; milbemycin oxime 3.8mg - dogs

Canada - English - Health Canada

boehringer ingelheim animal health canada inc. - afoxolaner; milbemycin oxime - tablet (chewable) - 37.5mg; 7.5mg - afoxolaner 37.5mg; milbemycin oxime 7.5mg - dogs

Canada - English - Health Canada

boehringer ingelheim animal health canada inc. - afoxolaner; milbemycin oxime - tablet (chewable) - 75mg; 15mg - afoxolaner 75mg; milbemycin oxime 15mg - dogs